C
Camilla M. Day
Researcher at Imperial College London
Publications - 5
Citations - 1700
Camilla M. Day is an academic researcher from Imperial College London. The author has contributed to research in topics: Psilocybin & Treatment-resistant depression. The author has an hindex of 4, co-authored 5 publications receiving 957 citations. Previous affiliations of Camilla M. Day include South London and Maudsley NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris,Mark Bolstridge,James Rucker,Camilla M. Day,David Erritzoe,Mendel Kaelen,Michael A P Bloomfield,James Rickard,Ben Forbes,Amanda Feilding,David Taylor,Steve Pilling,Valerie Curran,David J. Nutt +13 more
TL;DR: Preliminary support for the safety and efficacy of psilocybin for treatment-resistant depression is provided and motivates further trials, with more rigorous designs, to better examine the therapeutic potential of this approach.
Journal ArticleDOI
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.
Robin L. Carhart-Harris,Mark Bolstridge,Mark Bolstridge,Camilla M. Day,Camilla M. Day,James Rucker,James Rucker,Rosalind Watts,David Erritzoe,Mendel Kaelen,Bruna Giribaldi,Michael A P Bloomfield,Stephen Pilling,James Rickard,Ben Forbes,Amanda Feilding,David Taylor,HV Curran,David J. Nutt +18 more
TL;DR: Although limited conclusions can be drawn about treatment efficacy from open-label trials, tolerability was good, effect sizes large and symptom improvements appeared rapidly after just two psilocybin treatment sessions and remained significant 6 months post-treatment in a treatment-resistant cohort.
Journal ArticleDOI
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression:
TL;DR: It is suggested that psilocybin treatment for depression may work via paradigmatically novel means, antithetical to antidepressant medications, and some short-term talking therapies.
Journal ArticleDOI
Neural correlates of the DMT experience assessed with multivariate EEG
Christopher Timmermann,Leor Roseman,Michael Schartner,Raphael Milliere,Luke T. J. Williams,David Erritzoe,Suresh D. Muthukumaraswamy,Michael Ashton,Adam Bendrioua,Okdeep Kaur,Samuel Turton,Matthew M. Nour,Camilla M. Day,Robert Leech,David J. Nutt,Robin L. Carhart-Harris,Robin L. Carhart-Harris +16 more
TL;DR: Investigation of the effects of IV DMT on the power spectrum and signal diversity of human brain activity recorded via multivariate EEG found the emergence of oscillatory activity within the delta and theta frequency bands was found to correlate with the peak of the experience - particularly its eyes-closed visual component.
Posted ContentDOI
Neural correlates of the DMT experience as assessed via multivariate EEG
Christopher Timmermann,Leor Roseman,Michael Schartner,Raphael Milliere,Luke Williams,David Erritzoe,Suresh D. Muthukumaraswamy,Michael Ashton,Adam Bendrioua,Okdeep Kaur,Samuel Turton,Matthew M. Nour,Camilla M. Day,Robert Leech,David J. Nutt,Robin L. Carhart-Harris,Robin L. Carhart-Harris +16 more
TL;DR: The emergence of oscillatory activity within the delta and theta frequency bands was found to correlate with the peak of the experience, and particularly its eyes-closed visual component, and thus further the understanding of the neurobiological underpinnings of immersive states of consciousness.